ORKA

NASDAQStock

Oruka Therapeutics, Inc.

$42.05+2.10 (+5.24%)

52-Week Range

$6.78

$41.75

Key Stats

Market Cap

1.6B

P/E Ratio

—

Dividend Yield

57.25%

Beta

-0.44

Volume

971.7K

Avg Volume

510.0K

Performance

+27.75%

+47.11%

+151.81%

YTD

+47.68%

+251.14%

+63.73%

Price Chart

ETF Exposure

ORKA is held by 55 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	500	$17K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	500	$17K	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	500	$17K	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.00%	500	$17K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	500	$17K	$3.7M	0.70%

PreviousPage 2 of 2

About ORKA ETF Exposure

Oruka Therapeutics, Inc. (ORKA) is held by 55 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.6B, ORKA is a widely held institutional stock. The stock currently trades at $42.05 with a dividend yield of 57.25%. Investors can gain exposure to ORKA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ORKA, sorted by portfolio weight.